Doing such a large raise with the end goal being some time away was always going to demand a discount to get it completed, which it has been, and with guaranteed backing, especially when a deal has been touted as being on the cards.
However, to say there isn’t any value as you do below, just simply isn’t factual by any justifiable measure of reality. The market cap with dilution is now around €100m, with considerably over a third in cash.
The investment in Faron will now require patience, but the signal for a potential blockbuster drug is very much in play as survival was almost trebled in the difficult R/R population with a significantly overweight TP53 population.
Why would one spend time uttering such blatantly falsifiable information is beyond me. But it seems to be a theme on this board… and the usual suspects all jump on the bandwagon. I mean, surely there are better ways to spend one’s Easter Sunday…